No results were found for your search. Please adjust your search term or broaden your search criteria.
Still can't find what you are looking for? We can prepare Custom Research for you.
Abatacept is a biologic drug used to treat immune disorders such as rheumatoid arthritis, juvenile idiopathic arthritis, and psoriatic arthritis. It works by blocking the activity of a molecule called CTLA-4, which is involved in the body's immune response. Abatacept is administered through an intravenous infusion or subcutaneous injection. It is used to reduce inflammation and pain associated with these conditions, as well as to slow down the progression of joint damage.
Abatacept is a relatively new drug, having been approved by the US Food and Drug Administration in 2005. It is one of several biologic drugs used to treat immune disorders, and is often used in combination with other medications.
Some companies in the Abatacept market include Bristol-Myers Squibb, AstraZeneca, and Pfizer. Show Less Read more
